ロード中...

Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone

The thiazolidinedione class peroxisome proliferator-activated receptor gamma (PPARγ) agonists are restricted in clinical use as antidiabetic agents because of side effects such as edema, weight gain, and heart failure. The single and selective agonism of PPARγ is the main cause of these side effects...

詳細記述

保存先:
書誌詳細
出版年:Drug Des Devel Ther
主要な著者: Wang, Xue-Jiao, Zhang, Jun, Wang, Shu-Qing, Xu, Wei-Ren, Cheng, Xian-Chao, Wang, Run-Ling
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4232041/
https://ncbi.nlm.nih.gov/pubmed/25422585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S70383
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!